National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items – Subsection 99ACA(3) Determination 2017 (PB 82 of 2017) (Cth)

Case
No judgment structure available for this case.

PB 82 of 2017

National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items - Subsection 99ACA(3)) Determination 2017

National Health Act1953

I, LISA LA RANCE, Assistant Secretary, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ACA(3) of the National Health Act 1953.

Dated 19 September 2017

LISA LA RANCE

Assistant Secretary

Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health

1              Name of Instrument

(1)This instrument is the National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items – Subsection 99ACA(3) Determination 2017.

(2)This instrument may also be cited as PB 82 of 2017.

2              Commencement

   This instrument commences on the date of registration on the Federal Register of Legislation.

3              Revocation

The Determination under subsection 99ACA(3) of the National Health Act 1953 (PB 59 of 2007) is revoked.

4              Authority

This Determination is made under subsection 99ACA (3) of the National Health Act 1953.

5              Definitions

In this Determination:

Administrative price reduction means a non-statutory price reduction that has been agreed under section 85AD of the Act.

Note: Terms used in this Determination have the same meaning as in the Act – see section 13 of the Legislation Act 2003. These terms include:

·     pharmaceutical item

·     listed component drug

·     manner of administration

6              Class of pharmaceutical items

The class of pharmaceutical items identified in the Schedule, by listed component drug and manner of administration, have taken a 12.5% administrative price reduction.

Schedule

LISTED COMPONENT DRUG MANNER OF ADMINISTRATION
Aciclovir Oral
Amitriptyline Oral
Amoxycillin Oral
Amoxycillin with Clavulanic Acid Oral
Bisacodyl Oral
Bupropion Oral
Calcitriol Oral
Calcium Folinate Injection
Captopril Oral
Carboplatin Injection
Cefaclor Oral
Cefotaxime Injection
Ceftriaxone Injection
Cefuroxime Oral
Cephalexin Oral
Cimetidine Oral
Ciprofloxacin Oral
Cisplatin Injection
Citalopram Oral
Clarithromycin Oral
Codeine with Paracetamol Oral
Cromoglycic Acid Application to the eye
Dexamphetamine Oral
Docetaxel Injection
Dolasetron Injection
Dolasetron Oral
Doxorubicin Injection/Intravesical
Electrolyte Replacement (Oral) Oral
Enalapril Oral
Erythromycin Oral
Escitalopram Oral
Esomeprazole Oral
Etidronic Acid and Calcium Oral
Etoposide Injection
Famciclovir Oral
Famotidine Oral
Fluconazole Oral
Fluorouracil Injection
Fluoxetine Oral
Fluvastatin Oral
Fluvoxamine Oral
Fosinopril Oral
Frusemide Injection
Gabapentin Oral
Gliclazide Oral
Glimepiride Oral
Granisetron Oral
Granisetron Injection
Imipramine Oral
Ipratropium Inhalation
Irinotecan Injection
Lansoprazole Oral
Lamotrigine Oral
Levetiracetam Oral
Lisinopril Oral
Metformin Oral
Methotrexate Injection
Methylphenidate Oral
Mirtazapine Oral
Mitozantrone Injection
Moclobemide Oral
Naratriptan Oral
Nizatidine Oral
Omeprazole Oral
Ondansetron Injection
Ondansetron Oral
Oxaliplatin Injection
Oxcarbazepine Oral
Paclitaxel Injection
Pantoprazole Oral
Paracetamol Oral
Paroxetine Oral
Pemetrexed Injection
Perindopril Oral
Pravastatin Oral
Quinapril Oral
Rabeprazole Oral
Ramipril Oral
Ranitidine Oral
Reboxetine Oral
Roxithromycin Oral
Sertraline Oral
Simvastatin Oral
Sumatriptan Oral
Terbinafine Oral
Tiagabine Oral
Topiramate Oral
Tramadol Injection
Tramadol Oral
Trandolapril Oral
Tropisetron Injection
Tropisetron Oral
Valaciclovir Oral
Vigabatrin Oral
Vinorelbine Injection
Zolmitriptan Oral
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0